Angèle Kelder

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival

Anna van Rhenen, N Feller, Angèle Kelder et al. · Clinical Cancer Research · 2005 · 372 citations · Full text

Medicine, Hematology, Oncology +14

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia

Monique Terwijn, Wendelien Zeijlemaker, Angèle Kelder et al. · PLoS ONE · 2014 · 213 citations · Full text

Medicine, Hematology, Oncology +17

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Wendelien Zeijlemaker, Tim Grob, Rosa J. Meijer et al. · Leukemia · 2018 · 205 citations · Full text

Medicine, Hematology, Oncology +13

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Anna van Rhenen, Bijan Moshaver, Angèle Kelder et al. · Leukemia · 2007 · 191 citations

Medicine, Hematology, Oncology +17